THE ANTIATHEROGENIC POTENTIAL OF CALCIUM-ANTAGONISTS

被引：21

作者：

WEINSTEIN, DB

机构：

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1988年 / 12卷

关键词：

D O I：

10.1097/00005344-198812006-00008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S29 / S35

页数：7

共 52 条

[1]

BALDOUF LK, 1906, J MED RES, V15, P335

[2]

Blumenthal Herman T., 1944, AMER JOUR PATH, V20, P665

[3] MECHANISM OF PROTECTION FROM ATHEROSCLEROSIS BY VERAPAMIL IN THE CHOLESTEROL-FED RABBIT [J].

BLUMLEIN, SL ;

SIEVERS, R ;

KIDD, P ;

PARMLEY, WW .

AMERICAN JOURNAL OF CARDIOLOGY, 1984, 54 (07) :884-889

[4] INHIBITION OF CHOLESTERYL ESTER DEPOSITION IN MACROPHAGES BY CALCIUM ENTRY BLOCKERS - AN EFFECT DISSOCIABLE FROM CALCIUM ENTRY BLOCKADE [J].

DAUGHERTY, A ;

RATERI, DL ;

SCHONFELD, G ;

SOBEL, BE .

BRITISH JOURNAL OF PHARMACOLOGY, 1987, 91 (01) :113-118

[5] NIFEDIPINE INCREASES CHOLESTERYL ESTER HYDROLYTIC ACTIVITY IN LIPID-LADEN RABBIT ARTERIAL SMOOTH-MUSCLE CELLS - A POSSIBLE MECHANISM FOR ITS ANTIATHEROGENIC EFFECT [J].

ETINGIN, OR ;

HAJJAR, DP .

JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (05) :1554-1558

[6] CALCIUM-CHANNEL BLOCKERS STIMULATE LDL RECEPTOR SYNTHESIS IN HUMAN-SKIN FIBROBLASTS [J].

FILIPOVIC, I ;

BUDDECKE, E .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 136 (03) :845-850

[7]

FLECKENSTEIN A, 1984, CARDIOVASCULAR EFFEC, P480

[8]

FLECKENSTEIN A, 1986, AM J CARDIOL S, V19, P109

[9]

GINSBURG R, 1983, LAB INVEST, V49, P154

[10]

GUTMANN N, 1955, ARCH PATHOL, V59, P717

← 1 2 3 4 5 6 →